EcoDrugPlus

Ensembl ID : ENSMAUG00000009790
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Ensembl ID : ENSMAUG00000007708
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSMAUG00000007776
Gene Symbol: -
Cross references: -
166 Possible Orthologues:

Ensembl ID : ENSMAUG00000015589
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSMAUG00000016231
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSMAUG00000019982
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSMAUG00000020495
Gene Symbol: -
Cross references: -
173 Possible Orthologues:

Ensembl ID : ENSMAUG00000002274
Gene Symbol: -
Cross references: -
61 Possible Orthologues:

Ensembl ID : ENSMAUG00000005289
Gene Symbol: -
Cross references: -
73 Possible Orthologues:

Ensembl ID : ENSMAUG00000017616
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSMAUG00000020036
Gene Symbol: -
Cross references: -
158 Possible Orthologues:

Ensembl ID : ENSMAUG00000017250
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).